Warrant
Issued 2026
Shares Underlying
Exercise Price
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 30 of Ensysce Biosciences, Inc.'s SEC filings and found 16 warrant series, 4 convertibles, 9 shelf registrations and 5 completed offerings on file for ENSC. The latest dilution event on file is a registration statement on Oct 23, 2026. Analysis updated Nov 1, 2026.
Raise routes on file: effective shelf · latest dilution event 11 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Oct 23, 2026 · Registration
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Issued 2026
Shares Underlying
Exercise Price
Issued 2026
Shares Underlying
Exercise Price
Issued 2026
Shares Underlying
Exercise Price
Issued 2026
Shares Underlying
Exercise Price
Issued 2025
Shares Underlying
Exercise Price
Issued 2025
Shares Underlying
Exercise Price
Principal
Conversion Price
Principal
Conversion Price
Principal
Conversion Price
Principal
Conversion Price
Issued 2026
Total capacity
Remaining
Issued 2026
Total capacity
Remaining
Issued 2023
Total capacity
Remaining
Issued 2026
Total capacity
Remaining
Issued 2025
Total capacity
Remaining
Issued 2025
Total capacity
Remaining
Issued 2025
Gross proceeds
Price per share
Issued 2026
Gross proceeds
Price per share
Issued 2026
Gross proceeds
Price per share
Gross proceeds
Price per share
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z